Sucampo Pharma (SCMP) Posts Q3 Break Even EPS; Misses by 3c
SCMP Hot Sheet
EPS Growth %: +140.0%Financial Fact:
Research and development revenue: 2.59M
Today's EPS Names:
BRLI, TLB, TNP, More
Sucampo Pharmaceuticals, Inc (NASDAQ: SCMP) reports Q3 EPS of $0.00, versus the analyst estimate of $0.03. Revenue for the quarter was $16.40 million, which compares to the estimate of $18.37 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
- Pandora (P) Blows Up Expectations as Listener Hours Rip; Guides FY13 Ahead of Views
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
